Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis

In conclusion, desmopressin likely re duces periprocedural blood loss and the number of units of blood transfused in small trials with methodologic limitations. However, the risk of hypotension needs to be mitigated. Large trials should evaluate desmopressin alongside tranexamic acid and enroll patients with advanced kidney disease.
Source: Perioperative Medicine - Category: Surgery Source Type: research